AI-powered search
Try Polaris, our new AI-powered search!

How can dermatologists effectively position lebrikizumab as a treatment option to patients with atopic dermatitis, considering the variety of other available therapies?

Featuring Mona Shahriari, MD |

Dermatologist, Yale University School of Medicine
Central CT Dermatology
Cromwell, CT

| Published November 06, 2024

Related Media

Powered by Polaris TM